Auffarth Gerd 4
4 · Outlook Therapeutics, Inc. · Filed Mar 24, 2022
Insider Transaction Report
Form 4
Auffarth Gerd
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-23+21,878→ 21,878 totalExercise: $1.92Exp: 2032-03-23→ Common Stock (21,878 underlying)
Footnotes (1)
- [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall fully vest on the earlier of (i) March 23,2023; or (ii) the date of the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control.